##common.pageHeaderLogo.altText##

Original article

Vol. 155 No. 6 (2025)

The Swiss Endometriosis Database: a retrospective multicentre cohort study on pain levels and multimodal treatment needs of endometriosis patients

Cite this as:
Swiss Med Wkly. 2025;155:3854
Published
24.06.2025

Summary

STUDY AIMS: This study aimed to deepen the understanding of endometriosis symptoms, types, and therapy recommendations for Swiss endometriosis patients in Swiss-certified endometriosis centres in 2022.

METHODS:In this exploratory retrospective multicentre cohort study, data from 3538 women who had their first consultation at a certified endometriosis centre in Switzerland in 2022 were analysed retrospectively. Data were collected by using questionnaires that were filled out by the patient and the physician at the first consultation, to evaluate parameters that included the main reason for consultation, visual analogue scale (VAS) scores for pain, clinical findings and therapy recommendations.

RESULTS: This study analysed all patients who had provided consent and were diagnosed with endometriosis (n = 3403, 96.2%) during their first consultation at a Swiss-certified endometriosis centre in 2022. The median age was 33.0 years (11–66 years). Of 812 documented VAS scores, 71.6% of the patients felt general pain, resulting in a median VAS score for dysmenorrhoea of 8 (0–10). After the first examination, peritoneal endometriosis (n = 1453, 54.8%) was diagnosed most often, followed by adenomyosis (n = 1366, 51.5%), deep infiltrating endometriosis (n = 857, 32.3%) and cystic/ovarian endometriosis (n = 643, 24.2%). In 46.2% of the patients, more than one working hypothesis, with regard to their condition, was identified – in most cases, a combination of peritoneal endometriosis and adenomyosis (15.6%). Endocrine therapy was the most frequent treatment recommended (60.6%), followed by recommendations for medical pain therapy (57%), surgery (34.4%), complementary procedures (23.5%), reproductive therapy (5.7%) and multimodal pain therapy (5.6%). Analysis of correlations between symptoms, diagnosis and treatment recommendations showed only a few notable findings such as correlations between peritoneal endometriosis and hormonal-/medical treatment as well as correlations between deep infiltrating endometriosis and treatment recommendation for surgery.

CONCLUSION: The high VAS scores in dysmenorrhoea underline the degree of suffering of patients with endometriosis seeking consultation at a certified endometriosis centre. Most patients presented multiple phenotypes with uncorrelated symptoms and diverse as well as multimodal treatment options were indicated, underlining the complexity and individuality of the disease. 

References

  1. Shafrir AL, Farland LV, Shah DK, Harris HR, Kvaskoff M, Zondervan K, et al. Risk for and consequences of endometriosis: A critical epidemiologic review. Best Pract Res Clin Obstet Gynaecol. 2018 Aug;51:1–15. 10.1016/j.bpobgyn.2018.06.001
  2. de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet. 2010 Aug;376(9742):730–8. 10.1016/S0140-6736(10)60490-4
  3. Brosens I, Gordts S, Benagiano G. Endometriosis in adolescents is a hidden, progressive and severe disease that deserves attention, not just compassion. Hum Reprod. 2013 Aug;28(8):2026–31. 10.1093/humrep/det243
  4. Bird CC, McElin TW, Manalo-Estrella P. The elusive adenomyosis of the uterus—revisited. Am J Obstet Gynecol. 1972 Mar;112(5):583–93. 10.1016/0002-9378(72)90781-8
  5. Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020 Mar;382(13):1244–56. 10.1056/NEJMra1810764
  6. Missmer SA, Tu F, Soliman AM, Chiuve S, Cross S, Eichner S, et al. Impact of endometriosis on women’s life decisions and goal attainment: a cross-sectional survey of members of an online patient community. BMJ Open. 2022 Apr;12(4):e052765. 10.1136/bmjopen-2021-052765
  7. Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012 May;27(5):1292–9. 10.1093/humrep/des073
  8. Parlament. SDA KEYSTONE-SDA-ATS AG. Gezielte Forschung zu Frauenkrankheiten. 2023. Available from: https://www.parlament.ch/de/services/news/Seiten/2023/20230314115515858194158159038_bsd083.aspx
  9. Ständerat. SDA KEYSTONE-SDA-ATS AG. Stärkere Förderung der Erforschung von Endometriose. 2023. Available from: https://www.parlament.ch/de/services/news/Seiten/2023/20231211164138528194158159038_bsd137.aspx
  10. Bundesamt für Statistik (BFS). Demografische Bilanz nach Alter. 2023. Available from: https://www.pxweb.bfs.admin.ch/pxweb/de/px-x-0102020000_103/px-x-0102020000_103/px-x-0102020000_103.px/table/tableViewLayout2/
  11. Adjumed Collect. Adjumed. 2025. Internet: https://adjumed.com/
  12. Bourdel N, Alves J, Pickering G, Ramilo I, Roman H, Canis M. Systematic review of endometriosis pain assessment: how to choose a scale? Hum Reprod Update. 2015;21(1):136–52. 10.1093/humupd/dmu046
  13. Mabrouk M, Montanari G, Guerrini M, Villa G, Solfrini S, Vicenzi C, et al. Does laparoscopic management of deep infiltrating endometriosis improve quality of life? A prospective study. Health Qual Life Outcomes. 2011 Nov;9(1):98. 10.1186/1477-7525-9-98
  14. Wüest A, Limacher JM, Dingeldein I, Siegenthaler F, Vaineau C, Wilhelm I, et al. Pain Levels of Women Diagnosed with Endometriosis: Is There a Difference in Younger Women? J Pediatr Adolesc Gynecol. 2023 Apr;36(2):140–7. 10.1016/j.jpag.2022.10.011
  15. Andres MP, Riccio LG, Abrao HM, Manzini MS, Braga L, Abrao MS. Visual Analogue Scale Cut-off Point of Seven Represents Poor Quality of Life in Patients with Endometriosis. Reprod Sci. 2024 Apr;31(4:1146–50. 10.1007/s43032-023-01406-6
  16. Becker CM, Bokor A, Heikinheimo O, Horne A, Jansen F, Kiesel L, et al.; ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis. Hum Reprod Open. 2022 Feb;2022(2):hoac009. 10.1093/hropen/hoac009
  17. Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019 Apr;220(4):354.e1–12. 10.1016/j.ajog.2018.12.039
  18. von Theobald P, Cottenet J, Iacobelli S, Quantin C. Epidemiology of endometriosis in France: A large, nation-wide study based on hospital discharge data. BioMed Res Int. 2016;2016:3260952. 10.1155/2016/3260952
  19. Nirgianakis K, Ma L, McKinnon B, Mueller MD. Recurrence patterns after surgery in patients with different endometriosis subtypes: A long‐term hospital‐based cohort study. J Clin Med. 2020 Feb;9(2):496. 10.3390/jcm9020496
  20. Ávalos Marfil A, Barranco Castillo E, Martos García R, Mendoza Ladrón de Guevara N, Mazheika M. Epidemiology of endometriosis in spain and its autonomous communities: A large, nationwide study. Int J Environ Res Public Health. 2021 Jul;18(15):7861. 10.3390/ijerph18157861
  21. Chen I, Thavorn K, Yong PJ, Choudhry AJ, Allaire C. Hospital-Associated Cost of Endometriosis in Canada: A Population-Based Study. J Minim Invasive Gynecol. 2020;27(5):1178–87. 10.1016/j.jmig.2019.09.771
  22. Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril. 2014 Apr;101(4):927–35. 10.1016/j.fertnstert.2014.02.012
  23. M. Leonardi et al., “When to Do Surgery and When Not to Do Surgery for Endometriosis: A Systematic Review and Meta-analysis,” Feb. 01, 2020, Elsevier B.V. doi: 10.1016/j.jmig.2019.10.014.
  24. Bafort C, Beebeejaun Y, Tomassetti C, Bosteels J, Duffy JM. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev. 2020 Oct;10(10):CD011031. 10.1002/14651858.CD011031.pub3
  25. Comptour A, Pereira B, Lambert C, Chauvet P, Grémeau AS, Pouly JL, et al. Identification of Predictive Factors in Endometriosis for Improvement in Patient Quality of Life. J Minim Invasive Gynecol. 2020;27(3):712–20. 10.1016/j.jmig.2019.05.013
  26. Thiel PS, Donders F, Kobylianskii A, Maheux-Lacroix S, Matelski J, Walsh C, et al. The Effect of Hormonal Treatment on Ovarian Endometriomas: A Systematic Review and Meta-Analysis. J Minim Invasive Gynecol. 2024 Apr;31(4):273–9. 10.1016/j.jmig.2024.01.002
  27. Meinhold-Heerlein I, Zeppernick M, Wölfler MM, Janschek E, Bornemann S, Holtmann L, et al.; AG QS Endo of the Stiftung Endometrioseforschung (SEF). QS ENDO Pilot - A Study by the Stiftung Endometrioseforschung (SEF) on the Quality of Care Provided to Patients with Endometriosis in Certified Endometriosis Centers in the DACH Region. Geburtshilfe Frauenheilkd. 2023 May;83(7):835–42. 10.1055/a-2061-6845